Analysts made sharp moves across sectors on Monday. A bank downgrade, a pharma lift, and oil field services pressure stand out.
Truist Financial took the most notable hit. Analysts downgraded the stock, cutting the consensus recommendation lower. The $63.5B bank now sits at a weaker standing among peers. By contrast, PNC Financial Services received a target price upgrade. Its average target rose to $263.28 from $258.85.
In pharma, Biogen got a target lift. The average analyst target climbed to $221.96. Short interest sits at a modest 3.7% of free float. That suggests little bearish pressure despite the stock's recent volatility.
SLB faced a consensus target cut. The oilfield services giant saw its average price target trimmed to $61.79. Oil sector sentiment remains cautious amid energy price uncertainty.
On the tech side, CrowdStrike and Marvell Technology both received target price increases. CrowdStrike's average target rose to $181.53. Marvell's climbed to $252.26, reflecting continued AI infrastructure demand.
Nike saw another target cut. Its consensus target fell to $51.39. That underlines ongoing concern about the brand's recovery pace under new leadership.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
